Advertisement

Topics

Latest "PEOS bvba" News Stories

12:38 EDT 18th March 2019 | BioPortfolio

Here are the most relevant search results for "PEOS bvba" found in our extensive news archives from over 250 global news sources.

More Information about PEOS bvba on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about PEOS bvba for you to read. Along with our medical data and news we also list PEOS bvba Clinical Trials, which are updated daily. BioPortfolio also has a large database of PEOS bvba Companies for you to search.

Showing "PEOS bvba" News Articles, all 4

Thursday 28th February 2019

Biocartis Group NV: BIOCARTIS ANNOUNCES 2018 RESULTS AND 2019 OUTLOOK

   PRESS RELEASE: REGULATED INFORMATIONThursday, 28 February 2019, 07:00 CETBIOCARTIS ANNOUNCES 2018 RESULTS AND 2019 OUTLOOK Mechelen, Belgium, 28 February 2019 - Biocartis Group NV (the 'Company' or 'Biocartis'), an innovative molecular diagnostics company (Euronext Brussels: BCART), today announces its operational highlights and financial resul...


Tuesday 12th February 2019

PEOs Professional Employer Organizations Global Market Research and Forecast, 20152025 [Report Updated: 01011970] Prices from USD $2200

SummaryThe PEOs Professional Employer Organizations report provides an independent information about the PEOs Professional Employer Organizations industry supported by extensive research on factors such as industry segmentssize trends, inhibitors, dynamics, drivers, opportunities challenges, environment policy, cost overview, porter's five force analysis, and key companies profiles including ...

Tuesday 4th December 2018

Cilag collaborates with argenx to develop and commercialise cancer immunotherapy cusatuzumab

Cilag GmbH International, an affiliate of the Janssen Pharmaceutical Companies of Johnson & Johnson, has entered into a worldwide collaboration and license agreement with argenx BVBA and argenx SE, to develop and commercialize cusatuzumab (ARGX─110).


Thursday 6th September 2018

Biocartis Group NV: BIOCARTIS ANNOUNCES H1 2018 RESULTS

PRESS RELEASE: REGULATED INFORMATION Thursday, 6 September 2018, 07:00 CEST BIOCARTIS ANNOUNCES H1 2018 RESULTS Mechelen, Belgium, 6 September 2018 - Biocartis Group NV (the 'Company' or 'Biocartis'), an innovative molecular diagnostics company (Euronext Brussels: BCART), today announces its business highlights and financial results for the first half of 2018, prepa...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks